Does the media favor SGRY or THC?

In the previous week, Tenet Healthcare had 8 more articles in the media than Surgery Partners. MarketBeat recorded 10 mentions for Tenet Healthcare and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Tenet Healthcare's score of 0.86 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tenet Healthcare 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SGRY or HIMS?

In the previous week, Hims & Hers Health had 23 more articles in the media than Surgery Partners. MarketBeat recorded 25 mentions for Hims & Hers Health and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Hims & Hers Health's score of 0.55 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SGRY or PACS?

In the previous week, PACS Group had 8 more articles in the media than Surgery Partners. MarketBeat recorded 10 mentions for PACS Group and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat PACS Group's score of -0.05 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CAI or SGRY?

In the previous week, Caris Life Sciences had 1 more articles in the media than Surgery Partners. MarketBeat recorded 3 mentions for Caris Life Sciences and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Caris Life Sciences' score of 0.51 indicating that Surgery Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SGRY or BLLN?

In the previous week, Billiontoone had 4 more articles in the media than Surgery Partners. MarketBeat recorded 6 mentions for Billiontoone and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Billiontoone's score of -0.18 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Surgery Partners (SGRY) Competitors

$14.53 -0.02 (-0.14%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$14.51 -0.02 (-0.17%)

As of 07:04 AM Eastern

Compare

SGRY vs. THC, HIMS, PACS, CAI, and BLLN

Should you buy Surgery Partners stock or one of its competitors? MarketBeat compares Surgery Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surgery Partners include Tenet Healthcare (THC), Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), and Billiontoone (BLLN).

How does Surgery Partners compare to Tenet Healthcare?

Surgery Partners (NASDAQ:SGRY) and Tenet Healthcare (NYSE:THC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Surgery Partners currently has a consensus price target of $22.18, indicating a potential upside of 52.66%. Tenet Healthcare has a consensus price target of $244.32, indicating a potential upside of 35.18%. Given Surgery Partners' higher probable upside, equities research analysts plainly believe Surgery Partners is more favorable than Tenet Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Tenet Healthcare	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.82

Tenet Healthcare has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Tenet Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.57	-$77.90M	-$0.60	N/A
Tenet Healthcare	$21.87B	0.71	$1.41B	$19.23	9.40

In the previous week, Tenet Healthcare had 8 more articles in the media than Surgery Partners. MarketBeat recorded 10 mentions for Tenet Healthcare and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Tenet Healthcare's score of 0.86 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tenet Healthcare	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

95.4% of Tenet Healthcare shares are held by institutional investors. 2.0% of Surgery Partners shares are held by insiders. Comparatively, 1.0% of Tenet Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Surgery Partners has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market. Comparatively, Tenet Healthcare has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market.

Tenet Healthcare has a net margin of 7.94% compared to Surgery Partners' net margin of -2.28%. Tenet Healthcare's return on equity of 25.55% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
Tenet Healthcare	7.94%	25.55%	5.15%

Summary

Tenet Healthcare beats Surgery Partners on 12 of the 17 factors compared between the two stocks.

How does Surgery Partners compare to Hims & Hers Health?

Surgery Partners (NASDAQ:SGRY) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Hims & Hers Health has a net margin of -0.56% compared to Surgery Partners' net margin of -2.28%. Hims & Hers Health's return on equity of 6.10% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
Hims & Hers Health	-0.56%	6.10%	1.52%

Surgery Partners has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market.

63.5% of Hims & Hers Health shares are held by institutional investors. 2.0% of Surgery Partners shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Surgery Partners presently has a consensus target price of $22.18, indicating a potential upside of 52.66%. Hims & Hers Health has a consensus target price of $29.37, indicating a potential downside of 11.01%. Given Surgery Partners' stronger consensus rating and higher possible upside, research analysts clearly believe Surgery Partners is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Hims & Hers Health has lower revenue, but higher earnings than Surgery Partners. Hims & Hers Health is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.57	-$77.90M	-$0.60	N/A
Hims & Hers Health	$2.37B	3.22	$128.37M	-$0.09	N/A

In the previous week, Hims & Hers Health had 23 more articles in the media than Surgery Partners. MarketBeat recorded 25 mentions for Hims & Hers Health and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Hims & Hers Health's score of 0.55 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	12 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hims & Hers Health beats Surgery Partners on 10 of the 17 factors compared between the two stocks.

How does Surgery Partners compare to PACS Group?

Surgery Partners (NASDAQ:SGRY) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

PACS Group has a net margin of 4.49% compared to Surgery Partners' net margin of -2.28%. PACS Group's return on equity of 26.47% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
PACS Group	4.49%	26.47%	4.36%

PACS Group has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.57	-$77.90M	-$0.60	N/A
PACS Group	$5.29B	1.12	$191.54M	$1.56	23.90

In the previous week, PACS Group had 8 more articles in the media than Surgery Partners. MarketBeat recorded 10 mentions for PACS Group and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat PACS Group's score of -0.05 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Surgery Partners presently has a consensus target price of $22.18, suggesting a potential upside of 52.66%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 28.72%. Given Surgery Partners' stronger consensus rating and higher possible upside, research analysts clearly believe Surgery Partners is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

PACS Group beats Surgery Partners on 9 of the 14 factors compared between the two stocks.

How does Surgery Partners compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Surgery Partners (NASDAQ:SGRY) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Caris Life Sciences has a net margin of 3.75% compared to Surgery Partners' net margin of -2.28%. Caris Life Sciences' return on equity of 98.28% beat Surgery Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Surgery Partners	-2.28%	1.04%	0.41%

Caris Life Sciences has higher earnings, but lower revenue than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.13	-$68.09M	-$7.61	N/A
Surgery Partners	$3.31B	0.57	-$77.90M	-$0.60	N/A

Caris Life Sciences currently has a consensus price target of $27.56, suggesting a potential upside of 56.57%. Surgery Partners has a consensus price target of $22.18, suggesting a potential upside of 52.66%. Given Caris Life Sciences' higher probable upside, equities research analysts clearly believe Caris Life Sciences is more favorable than Surgery Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Caris Life Sciences had 1 more articles in the media than Surgery Partners. MarketBeat recorded 3 mentions for Caris Life Sciences and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Caris Life Sciences' score of 0.51 indicating that Surgery Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Caris Life Sciences beats Surgery Partners on 8 of the 14 factors compared between the two stocks.

How does Surgery Partners compare to Billiontoone?

Surgery Partners (NASDAQ:SGRY) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

Billiontoone has lower revenue, but higher earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgery Partners	$3.31B	0.57	-$77.90M	-$0.60	N/A
Billiontoone	$305.11M	15.72	$7.45M	$0.55	189.60

In the previous week, Billiontoone had 4 more articles in the media than Surgery Partners. MarketBeat recorded 6 mentions for Billiontoone and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.95 beat Billiontoone's score of -0.18 indicating that Surgery Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgery Partners	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Surgery Partners currently has a consensus target price of $22.18, suggesting a potential upside of 52.66%. Billiontoone has a consensus target price of $125.29, suggesting a potential upside of 20.14%. Given Surgery Partners' stronger consensus rating and higher probable upside, equities analysts plainly believe Surgery Partners is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has a net margin of 0.00% compared to Surgery Partners' net margin of -2.28%. Surgery Partners' return on equity of 1.04% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Surgery Partners	-2.28%	1.04%	0.41%
Billiontoone	N/A	N/A	N/A

Summary

Surgery Partners beats Billiontoone on 8 of the 14 factors compared between the two stocks.

Get Surgery Partners News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SGRY vs. The Competition

Export

Metric	Surgery Partners	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.90B	$8.69B	$6.45B	$12.38B
Dividend Yield	N/A	1.73%	2.69%	5.83%
P/E Ratio	-24.22	23.42	24.66	23.99
Price / Sales	0.57	18.08	526.33	107.23
Price / Cash	8.52	98.97	44.82	54.51
Price / Book	0.60	5.71	10.72	6.50
Net Income	-$77.90M	$174.80M	$3.56B	$336.88M
7 Day Performance	2.11%	0.15%	0.94%	-0.16%
1 Month Performance	8.43%	1.54%	0.36%	0.76%
1 Year Performance	-31.17%	8.61%	29.67%	28.49%

Surgery Partners Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SGRY Surgery Partners	3.7638 of 5 stars	$14.53 -0.1%	$22.18 +52.7%	-28.1%	$1.90B	$3.31B	N/A	16,000
THC Tenet Healthcare	4.5034 of 5 stars	$179.08 +2.5%	$244.16 +36.3%	+6.8%	$15.04B	$21.31B	9.31	99,000	Analyst Forecast
HIMS Hims & Hers Health	2.8494 of 5 stars	$30.10 +12.2%	$28.70 -4.6%	-21.6%	$6.21B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Down
PACS PACS Group	3.8491 of 5 stars	$36.23 -0.2%	$48.00 +32.5%	+192.0%	$5.74B	$5.29B	23.22	47,455	News Coverage Insider Trade
CAI Caris Life Sciences	4.4288 of 5 stars	$18.18 +1.2%	$27.56 +51.6%	N/A	$5.08B	$812.03M	N/A	1,846

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SGRY) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Surgery Partners (SGRY) Competitors

SGRY vs. THC, HIMS, PACS, CAI, and BLLN

How does Surgery Partners compare to Tenet Healthcare?

Summary

How does Surgery Partners compare to Hims & Hers Health?

Summary

How does Surgery Partners compare to PACS Group?

Summary

How does Surgery Partners compare to Caris Life Sciences?

Summary

How does Surgery Partners compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SGRY vs. The Competition

Surgery Partners Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Surgery Partners (SGRY) Competitors

SGRY vs. THC, HIMS, PACS, CAI, and BLLN

How does Surgery Partners compare to Tenet Healthcare?

Do analysts prefer SGRY or THC?

Which has stronger valuation and earnings, SGRY or THC?

Does the media favor SGRY or THC?

Do insiders and institutionals believe in SGRY or THC?

Which has more volatility & risk, SGRY or THC?

Is SGRY or THC more profitable?

Summary

How does Surgery Partners compare to Hims & Hers Health?

Is SGRY or HIMS more profitable?

Which has more risk and volatility, SGRY or HIMS?

Do institutionals & insiders believe in SGRY or HIMS?

Do analysts prefer SGRY or HIMS?

Which has better earnings & valuation, SGRY or HIMS?

Does the media favor SGRY or HIMS?

Summary

How does Surgery Partners compare to PACS Group?

Is SGRY or PACS more profitable?

Which has higher valuation & earnings, SGRY or PACS?

Does the media prefer SGRY or PACS?

Do analysts recommend SGRY or PACS?

Summary

How does Surgery Partners compare to Caris Life Sciences?

Is CAI or SGRY more profitable?

Which has better valuation and earnings, CAI or SGRY?

Do analysts recommend CAI or SGRY?

Does the media refer more to CAI or SGRY?

Summary

How does Surgery Partners compare to Billiontoone?

Which has stronger valuation and earnings, SGRY or BLLN?

Does the media prefer SGRY or BLLN?

Do analysts recommend SGRY or BLLN?

Is SGRY or BLLN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SGRY vs. The Competition

Surgery Partners Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools